Accueil CHUV
Navigation menu

Centre des tumeurs thoraciques

Publications

Les intervenants du Centre des tumeurs thoraciques publient chaque année les résultats de leurs travaux de recherche dans diverses revues suisses et internationales.

2016
2015

Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities.

Wang X, Gronchi F, Bensimon M, Mercier T, Decosterd LA, Wagnières G, Debefve E, Ris HB, Letovanec I, Peters S, Perentes JY

Lasers Surg Med. 2015 Dec;47(10):807-16

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17⁄04): a randomised, international, multicentre phase 2 trial.

Stahel RA, Riesterer O, Xyrafas A, Opitz I, Beyeler M, Ochsenbein A, Früh M, Cathomas R, Nackaerts K, Peters S, Mamot C, Zippelius A, Mordasini C, Caspar CB, Eckhardt K, Schmid RA, Aebersold DM, Gautschi O, Nagel W, Töpfer M, Krayenbuehl J, Ribi K, Cierni

Lancet Oncol. 2015 Dec;16(16):1651-8

BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung Cancer.

Nguyen-Ngoc T, Bouchaab H, Adjei AA, Peters S

J Thorac Oncol. 2015 Oct;10(10):1396-403

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

Gautschi O, Milia J, Cabarrou B, Bluthgen MV, Besse B, Smit EF, Wolf J, Peters S, Früh M, Koeberle D, Oulkhouir Y, Schuler M, Curioni-Fontecedro A, Huret B, Kerjouan M, Michels S, Pall G, Rothschild S, Schmid-Bindert G, Scheffler M, Veillon R, Wannesson L

J Thorac Oncol. 2015 Oct;10(10):1451-7

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.

Pless M, Stupp R, Ris HB, Stahel RA, Weder W, Thierstein S, Gerard MA, Xyrafas A, Früh M, Cathomas R, Zippelius A, Roth A, Bijelovic M, Ochsenbein A, Meier UR, Mamot C, Rauch D, Gautschi O, Betticher DC, Mirimanoff RO, Peters S, SAKK Lung Cancer Project G

Lancet. 2015 Sep 12;386(9998):1049-56

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Baas P, Fennell D, Kerr KM, Van Schil PE, Haas RL, Peters S, ESMO Guidelines Committee.

Ann Oncol. 2015 Sep;26 Suppl 5:v31-9

Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.

Gautschi O, Mach N, Rothschild SI, Li Q, Stahel RA, Zippelius A, Cathomas R, Früh M, Betticher DC, Peters S, Rauch D, Feilchenfeldt J, Bubendorf L, Savic S, Jaggi R, Leibundgut EO, Largiadèr C, Brutsche M, Pilop C, Stalder L, Pless M, Ochsenbein AF, Swiss

Clin Lung Cancer. 2015 Sep;16(5):358-65

Incidence and Risk Factors of Abdominal Complications After Lung Transplantation.

Grass F, Schäfer M, Cristaudi A, Berutto C, Aubert JD, Gonzalez M, Demartines N, Ris HB, Soccal PM, Krueger T

World J Surg. 2015 Sep;39(9):2274-81

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Eberhardt WE, De Ruysscher D, Weder W, Le Péchoux C, De Leyn P, Hoffmann H, Westeel V, Stahel R, Felip E, Peters S, Panel Members.

Ann Oncol. 2015 Aug;26(8):1573-88

Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia.

Babaker M, Breault S, Beigelman C, Lazor R, Aebischer N, Qanadli SD

Swiss Med Wkly. 2015;145:w14151

Extensive Endobronchial Lesions in a Patient With Stage 0 Sarcoidosis.

Lovis A, Noirez L, Letovanec I, Walker A

Arch Bronconeumol. 2015 Jul;51(7):367-8

Thoracoscopic resection of pulmonary metastasis: current practice and results.

Perentes JY, Krueger T, Lovis A, Ris HB, Gonzalez M

Crit Rev Oncol Hematol. 2015 Jul;95(1):105-13

Fluoroscopic-Guided Radial Endobronchial Ultrasound Without Guide Sheath For Peripheral Pulmonary Lesions: A Safe And Efficient Combination.

Casutt A, Prella M, Beigelman-Aubry C, Fitting JW, Nicod L, Koutsokera A, Lovis A

Arch Bronconeumol. 2015 Jul;51(7):338-43

The virtuous circle of building evidence in abdominal interventional radiology.

Denys A, de Baere T

Diagn Interv Imaging. 2015 Jun;96(6):529-30

Present standards and future perspectives in the treatment of metastatic non-small cell lung cancer.

Zimmermann S, Peters S

Cancer Metastasis Rev. 2015 Jun;34(2):173-82

Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis.

Casutt A, Bouchaab H, Beigelman-Aubry C, Bourhis J, Lovis A, Matzinger O

Br J Radiol. 2015 May;88(1049):20140687

A 3-step therapeutic strategy for severe alveolar proteinosis.

Noirez L, Koutsokera A, Pantet O, Duss FR, Eggimann P, Tozzi P, Gonzalez M, Coronado M, Nicod LP, Lovis A

Ann Thorac Surg. 2015 Apr;99(4):1456-8

Vacuum-assisted closure device for the management of infected postpneumonectomy chest cavities.

Perentes JY, Abdelnour-Berchtold E, Blatter J, Lovis A, Ris HB, Krueger T, Gonzalez M

J Thorac Cardiovasc Surg. 2015 Mar;149(3):745-50

Lung cancer. How much platinum-based chemotherapy is enough in NSCLC?

Peters S, Adjei AA

Nat Rev Clin Oncol. 2015 Jan;12(1):8-10

Granulomatous Reaction to Pneumocystis jirovecii Diagnosed in a Bronchoalveolar Lavage: A Case Report.

Nobile A, Valenti A, Aubert JD, Beigelman C, Letovanec I, Bongiovanni M

Acta Cytol. 2015;59(3):284-8
2014

[Idiopathic pulmonary fibrosis: recent diagnostic and therapeutic advances].

Petitpierre N, Beigelman C, Letovanec I, Nicod LP, Lazor R

Rev Med Suisse. 2014 Nov 19;10(451):2208-10, 2212-3

Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters.

Peters S, Weder W, Dafni U, Kerr KM, Bubendorf L, Meldgaard P, O’Byrne KJ, Wrona A, Vansteenkiste J, Felip E, Marchetti A, Savic S, Lu S, Smit E, Dingemans AM, Blackhall FH, Baas P, Camps C, Rosell R, Stahel RA, ETOP Lungscape Investigators.

J Thorac Oncol. 2014 Nov;9(11):1675-84

Pan-HER inhibition in EGFR wild-type non-small-cell lung cancer.

Peters S, Smit E

Lancet Oncol. 2014 Nov;15(12):1289-90

Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

Kerr KM, Bubendorf L, Edelman MJ, Marchetti A, Mok T, Novello S, O’Byrne K, Stahel R, Peters S, Felip E, Panel Members., Panel Members.

Ann Oncol. 2014 Sep;25(9):1681-90

Complications of valve lung volume reduction in a case of previous pleurodesis.

Koutsokera A, Noirez L, Gonzalez M, Beigelman-Aubry C, Ris HB, Aubert JD, Lovis A

Ann Thorac Surg. 2014 Sep;98(3):e71-2

[Idiopathic pleuroparenchymal fibroelastosis, a new entity].

Lazor R, Letovanec I, Beigelman C

Rev Prat. 2014 Sep;64(7):938

Oral epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: comparative pharmacokinetics and drug-drug interactions.

Peters S, Zimmermann S, Adjei AA

Cancer Treat Rev. 2014 Sep;40(8):917-26

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

Blackhall FH, Peters S, Bubendorf L, Dafni U, Kerr KM, Hager H, Soltermann A, O’Byrne KJ, Dooms C, Sejda A, Hernández-Losa J, Marchetti A, Savic S, Tan Q, Thunnissen E, Speel EJ, Cheney R, Nonaka D, de Jong J, Martorell M, Letovanec I, Rosell R, Stahel RA

J Clin Oncol. 2014 Sep 1;32(25):2780-7

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Reck M, Popat S, Reinmuth N, De Ruysscher D, Kerr KM, Peters S, ESMO Guidelines Working Group.

Ann Oncol. 2014 Sep;25 Suppl 3:iii27-39

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.

Vansteenkiste J, Crinò L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, Stahel R, Peters S, Felip E, Panel Members.

Ann Oncol. 2014 Aug;25(8):1462-74

Integrated care pathways for airway diseases (AIRWAYS-ICPs).

European Innovation Partnership on Active and Healthy Ageing, Action Plan B3., Mechanisms of the Development of Allergy, WP 10., Global Alliance against Chronic Respiratory Diseases., Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Mae

Eur Respir J. 2014 Aug;44(2):304-23

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease.

Besse B, Adjei A, Baas P, Meldgaard P, Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R, Felip E, Peters S, Panel Members., ESMO.

Ann Oncol. 2014 Aug;25(8):1475-84

Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases.

Zimmermann S, Dziadziuszko R, Peters S

Cancer Treat Rev. 2014 Jul;40(6):716-22

[Lung volume reduction (LVR) in severe emphysema: a multidisciplinary approach].

Lovis A, Krueger T, Perentes JY, Ris HB, Egger B, Beigelman C, Nicod L, Aubert JD, Gonzalez M

Rev Med Suisse. 2014 Jun 18;10(435):1337-42

Use of combined suspension laryngoscopy and jet ventilation for Y-shaped airway stents delivery.

Monnier Y, Chollet-Rivier M, Gonzalez M, Nicod L, Simon C, Lovis A

Ann Thorac Surg. 2014 Jun;97(6):2208-10

[Postoperative radiation therapy in lung carcinom].

Bouchaab H, Peters S, Ozsahin M, Peguret N, Gonzales M, Lovis A

Rev Med Suisse. 2014 May 21;10(431):1110-3

Low-Dose Vascular Photodynamic Therapy Decreases Tumor Interstitial Fluid Pressure, which Promotes Liposomal Doxorubicin Distribution in a Murine Sarcoma Metastasis Model.

Perentes JY, Wang Y, Wang X, Abdelnour E, Gonzalez M, Decosterd L, Wagnieres G, van den Bergh H, Peters S, Ris HB, Krueger T

Transl Oncol. 2014 May 13

Targeted therapy in NSCLC driven by HER2 insertions.

Peters S, Zimmermann S

Transl Lung Cancer Res. 2014 Apr;3(2):84-8

An unusual and unknown complication of endobronchial valves.

Lovis A, Lahzami S, Gonzalez M, Pasche A

Ann Thorac Surg. 2014 Apr;97(4):e117

ALK inhibitors in the treatment of advanced NSCLC.

Gridelli C, Peters S, Sgambato A, Casaluce F, Adjei AA, Ciardiello F

Cancer Treat Rev. 2014 Mar;40(2):300-6

Isolated mediastinal necrotizing granulomatous lymphadenopathy due to cat-scratch disease.

Lovis A, Clerc O, Lazor R, Jaton K, Greub G

Infection. 2014 Feb;42(1):153-4
2013

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.

Gautschi O, Peters S, Zoete V, Aebersold-Keller F, Strobel K, Schwizer B, Hirschmann A, Michielin O, Diebold J

Lung Cancer. 2013 Nov;82(2):365-7

Practical tips and tricks with recently approved molecular targeted agents in non-small-cell lung cancer.

Zimmermann S, Peters S

EJC Suppl. 2013 Sep;11(2):307-9

Treatment and detection of ALK-rearranged NSCLC.

Peters S, Taron M, Bubendorf L, Blackhall F, Stahel R

Lung Cancer. 2013 Aug;81(2):145-54

Impact of induction therapy on airway complications after sleeve lobectomy for lung cancer.

Gonzalez M, Litzistorf Y, Krueger T, Popeskou SG, Matzinger O, Ris HB, Gronchi F, Lovis A, Peters S

Ann Thorac Surg. 2013 Jul;96(1):247-52

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives.

Mazières J, Peters S, Lepage B, Cortot AB, Barlesi F, Beau-Faller M, Besse B, Blons H, Mansuet-Lupo A, Urban T, Moro-Sibilot D, Dansin E, Chouaid C, Wislez M, Diebold J, Felip E, Rouquette I, Milia JD, Gautschi O

J Clin Oncol. 2013 Jun 1;31(16):1997-2003

The intrathoracic vacuum-assisted closure device in case of post-pneumonectomy empyema.

Krueger T, Perentes JY, Ris HB, Gonzalez M

Eur J Cardiothorac Surg. 2013 May;43(5):1077

A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?

Demierre N, Zoete V, Michielin O, Stauffer E, Zimmermann DR, Betticher DC, Peters S

Lung Cancer. 2013 Apr;80(1):81-4

Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancer.

Peters S, Meylan E

Curr Opin Oncol. 2013 Mar;25(2):137-44

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

Gautschi O, Dingemans AM, Crowe S, Peters S, Roder H, Grigorieva J, Roder J, Zappa F, Pless M, Brutsche M, Baty F, Bubendorf L, Hsu Schmitz SF, Na KJ, Carbone D, Stahel R, Smit E

Lung Cancer. 2013 Jan;79(1):59-64

Diagnosis and management of chronic obstructive pulmonary disease: the Swiss guidelines. Official guidelines of the Swiss Respiratory Society.

Russi EW, Karrer W, Brutsche M, Eich C, Fitting JW, Frey M, Geiser T, Kuhn M, Nicod L, Quadri F, Rochat T, Steurer-Stey C, Stolz D, Swiss Respiratory Society.

Respiration. 2013;85(2):160-74
2012

Impact of lung function changes after induction radiochemotherapy on resected T4 non-small cell lung cancer outcome.

Perentes J, Bopp S, Krueger T, Gonzalez M, Jayet PY, Lovis A, Matzinger O, Ruffieux C, Ris HB, Letovanec I, Peters S

Ann Thorac Surg. 2012 Dec;94(6):1815-22

Therapeutic advances in non-small cell lung cancer.

Vallières E, Peters S, Van Houtte P, Dalal P, Lim E

Thorax. 2012 Dec;67(12):1097-101

[Computed tomography screening for lung cancer].

Lazor R, Cornuz J, Lovis A, Nicod LP

Rev Med Suisse. 2012 Nov 21;8(363):2206-11

[Management pulmonary metastases: when operate?].

Gonzalez M, Peters S, Wang Y, Ris HB, Krueger T

Rev Med Suisse. 2012 Jun 20;8(346):1326-31

[VATS lobectomy for early-stage primary lung cancer].

Krueger T, Perentes JY, Peters S, Ris HB, Gonzalez M

Rev Med Suisse. 2012 Jun 20;8(346):1337-41

Pulmonary sarcoid-like granulomatosis induced by ipilimumab.

Berthod G, Lazor R, Letovanec I, Romano E, Noirez L, Mazza Stalder J, Speiser DE, Peters S, Michielin O

J Clin Oncol. 2012 Jun 10;30(17):e156-9

Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density.

Wang Y, Gonzalez M, Cheng C, Haouala A, Krueger T, Peters S, Decosterd LA, van den Bergh H, Perentes JY, Ris HB, Letovanec I, Debefve E

Lasers Surg Med. 2012 Apr;44(4):318-24

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Ca

Pesce GA, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar CB, Fischer N, Anchisi S, Peters S, Cathomas R, Bernhard J, Kotrubczik NM, D’Addario G, Pilop C, Weber DC, Bodis S, Pless M, Mayer M, Stupp R

Eur J Cancer. 2012 Feb;48(3):377-84

[Management of anterior mediastinal masses in adults].

Gonzalez M, Ris HB, Krueger T, Jayet PY

Rev Mal Respir. 2012 Feb;29(2):138-48

¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.

Letovanec I, Allenbach G, Mihaescu A, Nicod Lalonde M, Schmidt S, Stupp R, Fitting JW, Boubaker A, Ris HB, Prior JO

Nuklearmedizin. 2012;51(5):186-93

Factors associated with the mediastinal spread of cervical necrotizing fasciitis.

Petitpas F, Blancal JP, Mateo J, Farhat I, Naija W, Porcher R, Beigelman C, Boudiaf M, Payen D, Herman P, Mebazaa A

Ann Thorac Surg. 2012 Jan;93(1):234-8